Please enable Javascript on your browser for a better experience.
The Apolipoprotein A1 (Apo A1) Test measures levels of Apo A1, the main protein in HDL cholesterol, to assess heart and vascular health. Higher levels are linked to protective “good” cholesterol, while low levels may increase risk of heart disease, stroke, or metabolic disorders. Doctors use this test with lipid panels to evaluate cardiovascular risk, monitor therapy, and guide prevention strategies for cholesterol balance and heart health.
The Apolipoprotein A1 and B Test measures Apo A1, the main protein in HDL cholesterol, and Apo B, the primary protein in LDL and VLDL cholesterol. Together, these markers and the ApoB/A1 ratio provide a clearer picture of cardiovascular risk than standard lipid panels. High ApoB or low Apo A1 may signal heart disease, stroke, or atherosclerosis. Doctors use this test to evaluate cholesterol balance, monitor therapy, and guide prevention of cardiovascular conditions.
The Cardio IQ™ Apolipoprotein A1 Test measures ApoA1, the main protein in HDL cholesterol. Higher ApoA1 levels are generally linked to lower cardiovascular risk. This test helps evaluate heart health, lipid metabolism, and supports assessment of cardiovascular disease risk.
The CVD-2 High Cholesterol Testing panel is an advanced diagnostic tool designed to provide a comprehensive assessment of cardiovascular health and risks associated with cholesterol levels and other significant markers. This panel includes tests for Apolipoprotein A1 and B, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Lipoprotein Fractionation, Ion Mobility, and VLDL Cholesterol.
The CVD-3 High Cholesterol Testing panel is a thorough diagnostic tool aimed at evaluating cardiovascular health by examining a broad spectrum of lipid profiles, inflammatory markers, and other specific tests related to heart disease risk. This panel includes Apolipoprotein A1, Apolipoprotein B, Direct LDL, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Cardio IQ™ Lipoprotein Fractionation, Ion Mobility, LP PLA2 Activity, and VLDL Cholesterol.
The CVD-4 High Cholesterol Testing panel represents the most comprehensive assessment in the series of cardiovascular diagnostics. It is designed to provide an extensive evaluation of cardiovascular risk factors, including genetic predispositions, lipid profiles, inflammatory markers, and more. This panel includes the ApoE Genotype, Apolipoprotein A1 and B, Direct LDL, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Lipoprotein Fractionation, LP PLA2 Activity, and VLDL Cholesterol.